Similar articles for PMID: 27477485

Year	Number of Results
1907	1
2000	1
2002	1
2003	3
2004	1
2005	9
2006	4
2007	5
2008	5
2009	7
2010	3
2011	7
2012	7
2013	7
2014	13
2015	12
2016	16
2017	19
2018	25
2019	18
2020	19
2021	8
2022	14
2023	2
2024	0

1

Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double blind, placebo controlled study.

Azpiroz F, Dubray C, Bernalier-Donadille A, Cardot JM, Accarino A, Serra J, Wagner A, Respondek F, Dapoigny M. Azpiroz F, et al. Neurogastroenterol Motil. 2017 Feb;29(2). doi: 10.1111/nmo.12911. Epub 2016 Jul 31. Neurogastroenterol Motil. 2017. PMID: 27477485 Clinical Trial.

2

Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.

Pinto-Sanchez MI, Hall GB, Ghajar K, Nardelli A, Bolino C, Lau JT, Martin FP, Cominetti O, Welsh C, Rieder A, Traynor J, Gregory C, De Palma G, Pigrau M, Ford AC, Macri J, Berger B, Bergonzelli G, Surette MG, Collins SM, Moayyedi P, Bercik P. Pinto-Sanchez MI, et al. Gastroenterology. 2017 Aug;153(2):448-459.e8. doi: 10.1053/j.gastro.2017.05.003. Epub 2017 May 5. Gastroenterology. 2017. PMID: 28483500 Free article. Clinical Trial.

3

The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.

Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG. Ki Cha B, et al. J Clin Gastroenterol. 2012 Mar;46(3):220-7. doi: 10.1097/MCG.0b013e31823712b1. J Clin Gastroenterol. 2012. PMID: 22157240 Clinical Trial.

4

Human milk oligosaccharide supplementation in irritable bowel syndrome patients: A parallel, randomized, double-blind, placebo-controlled study.

Iribarren C, Törnblom H, Aziz I, Magnusson MK, Sundin J, Vigsnaes LK, Amundsen ID, McConnell B, Seitzberg D, Öhman L, Simrén M. Iribarren C, et al. Neurogastroenterol Motil. 2020 Oct;32(10):e13920. doi: 10.1111/nmo.13920. Epub 2020 Jun 14. Neurogastroenterol Motil. 2020. PMID: 32536023 Clinical Trial.

5

Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome.

Hustoft TN, Hausken T, Ystad SO, Valeur J, Brokstad K, Hatlebakk JG, Lied GA. Hustoft TN, et al. Neurogastroenterol Motil. 2017 Apr;29(4). doi: 10.1111/nmo.12969. Epub 2016 Oct 16. Neurogastroenterol Motil. 2017. PMID: 27747984 Clinical Trial.

6

Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.

Yoon JS, Sohn W, Lee OY, Lee SP, Lee KN, Jun DW, Lee HL, Yoon BC, Choi HS, Chung WS, Seo JG. Yoon JS, et al. J Gastroenterol Hepatol. 2014 Jan;29(1):52-9. doi: 10.1111/jgh.12322. J Gastroenterol Hepatol. 2014. PMID: 23829297 Clinical Trial.

7

The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome.

Iribarren C, Magnusson MK, Vigsnæs LK, Aziz I, Amundsen ID, Šuligoj T, Juge N, Patel P, Sapnara M, Johnsen L, Sørensen N, Sundin J, Törnblom H, Simrén M, Öhman L. Iribarren C, et al. Nutrients. 2021 Oct 27;13(11):3836. doi: 10.3390/nu13113836. Nutrients. 2021. PMID: 34836092 Free PMC article. Clinical Trial.

8

The effects of sildenafil on rectal sensitivity and tone in patients with the irritable bowel syndrome.

Gonçalves de Medeiros MT, de Oliveira RB, dos Santos AA, de Leopoldino DM, Lima MC, Nobre RA, Nobre e Souza MÂ. Gonçalves de Medeiros MT, et al. Aliment Pharmacol Ther. 2012 Mar;35(5):577-86. doi: 10.1111/j.1365-2036.2011.04977.x. Epub 2012 Jan 10. Aliment Pharmacol Ther. 2012. PMID: 22229478 Free article. Clinical Trial.

9

Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.

Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L. Ducrotte P, et al. Aliment Pharmacol Ther. 2005 Feb 15;21(4):435-44. doi: 10.1111/j.1365-2036.2005.02330.x. Aliment Pharmacol Ther. 2005. PMID: 15709995 Free article. Clinical Trial.

10

Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome.

Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR. Silk DB, et al. Aliment Pharmacol Ther. 2009 Mar 1;29(5):508-18. doi: 10.1111/j.1365-2036.2008.03911.x. Epub 2008 Dec 2. Aliment Pharmacol Ther. 2009. PMID: 19053980 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

176 results

Results by year